WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018057712) METHODS FOR TREATING SMALL CELL LUNG CANCERS BY USING PHARMACEUTICAL COMPOSITIONS OR COMBINATIONS COMPRISING INDOLIZINO (6,7-B) INDOLE DERIVATIVES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/057712    International Application No.:    PCT/US2017/052675
Publication Date: 29.03.2018 International Filing Date: 21.09.2017
IPC:
A61K 31/437 (2006.01), A61K 31/40 (2006.01), C07D 471/14 (2006.01)
Applicants: ACADEMIA SINICA; 128, Academia Road, Section 2 Nankang Taipei, 115 (TW).
SU, Tsann-Long [US/US]; (US)
Inventors: SU, Tsann-Long; (US).
LEE, Te-Chang; (TW)
Agent: MASS, Clifford, J.; (US).
RICHARDS, John; (US).
CORD, Janet, I.; (US).
DIPERAN, Raymond, A.; (US)
Priority Data:
62/398,293 22.09.2016 US
Title (EN) METHODS FOR TREATING SMALL CELL LUNG CANCERS BY USING PHARMACEUTICAL COMPOSITIONS OR COMBINATIONS COMPRISING INDOLIZINO (6,7-B) INDOLE DERIVATIVES
(FR) MÉTHODES DE TRAITEMENT DE CANCERS BRONCHIQUES À PETITES CELLULES AU MOYEN DE COMPOSITIONS OU COMBINAISONS PHARMACEUTIQUES COMPRENANT DES DÉRIVÉS INDOLIZINO (6,7-B) INDOLE
Abstract: front page image
(EN)A method for treating small cell lung cancer (SCLC) is provided. In the method, a therapeutically effective amount of a compound of Formula I: (I) wherein R1, R2 and R3 have the definitions disclosed in the specification is administered alone or in combination with one or more anticancer agents, or surgery, radiation therapy, chemotherapy, and/or targeted therapy.
(FR)L'invention concerne une méthode de traitement du cancer bronchique (du poumon) à petites cellules (CBPC). Dans la méthode, une quantité thérapeutiquement efficace d'un composé de formule I : (I) dans laquelle R1, R2 et R3 ont les définitions décrites dans la description, est administré seul ou en combinaison avec un ou plusieurs agents anticancéreux, ou d'une chirurgie, d'une radiothérapie, d'une chimiothérapie et/ou d'une thérapie ciblée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)